| Application no. and date | 04764762.3 (espacenet) (Federated) (European Patent Register), 20040902 | | Patent/reg. no. and date | DK/EP 1663287, 20090715 | | Publication date | 20060607 | | Priority no. and date | GB 0320638, 20030903 | | EP pub. no. and date |
EP 1663287 20060607 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | 136601 | | Inventor | HIJIKATA, Makoto,
Fujinomori Godoshukusha 217, Kan-yuchi,
Ikenouchicho,
Fukakusa,
Fushimi-ku
Kyoto 6120031, JP,
SHIMOTOHNO, Kunitada,
Fushimi Godosyukusya 245, Nishibugyo-cho,
Fushimi-ku
Kyoto 612-8104, JP,
WATASHI, Koichi,
Ichijo-heights 203, 232-1 Nishinkuchicho,
Nishinotoin-nishiiru
Ichijo-dori,
Kamigyo-Ku,
Kyoto 602-0925, JP | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 38/13 (2006.01) , A61P 31/14 (2006.01) | | Title | Anvendelse af modificerede cyclosporiner til behandling af HCV-sygdomme | | Int. application no. | EP2004009804 | | Int. publication no. | WO2005021028 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
